Internal Medicine, Endocrinology, Diabetes, & Metabolism · Johnston, RI
NPI
1508152778
Since 2011
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
1539 Atwood Ave Ste 304
Johnston, RI, 02919
Phone (401) 519-3335
Groups this clinician bills Medicare through
Medicare paid, 2024
$40K
789 services
Medicare patients, 2024
214
Average age 73
Drug cost, 2024
$2.6M
6,927 prescriptions
Company payments, 2025
$38.36
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Stephanie Curry was code 99214 (office e&m - established), 343 times for 172 patients. In total Stephanie Curry billed 789 services in 10 codes, and Medicare paid $40K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-07-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 343 | 172 | $89.84 | $31K |
| 83036 Blood Count | Office | 172 | 102 | $9.09 | $1,563 |
| 82962 Clinical Chemistry | Office | 103 | 66 | $3.12 | $321 |
| 95251 Test - Miscellaneous | Office | 100 | 45 | $25.75 | $2,575 |
| 99213 Office E&M - Established | Office | 50 | 41 | $54.36 | $2,718 |
By year: 2022 $44K for 932 services; 2023 $42K for 858 services; 2024 $40K for 789 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 172 | 102 | $9.09 | $1,563 |
| 82962 Clinical Chemistry | 103 | 66 | $3.12 | $321 |
Medicare prescription drug claims, 2024
In 2024, the drug Stephanie Curry prescribed most often to Medicare patients was Levothyroxine Sodium, with 728 prescriptions and refills. In total Stephanie Curry wrote 6,927 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 728 | 1,810 | 171 | $11K |
| Glipizide Er Glipizide | 634 | 1,691 | 151 | $15K |
| Ozempic Semaglutide | 549 | 672 | 85 | $629K |
| Metformin Hcl Er Metformin Hcl | 425 | 1,130 | 114 | $4,687 |
| Jardiance Empagliflozin | 377 | 559 | 66 | $320K |
| Glimepiride Generic | 302 | 688 | 69 | $3,669 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 282 | 515 | 87 | $23K |
| Trulicity Dulaglutide | 268 | 285 | 39 | $273K |
| Metformin Hcl Generic | 205 | 573 | 62 | $2,461 |
| Mounjaro Tirzepatide | 180 | 189 | 33 | $199K |
| Humulin R U-500 Kwikpen Insulin Regular, Human | 178 | 261 | 31 | $217K |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | 174 | 336 | 43 | $134K |
| Humalog Kwikpen U-100 Insulin Lispro | 143 | 226 | 46 | $33K |
| Repaglinide Generic | 118 | 244 | 26 | $3,412 |
| Atorvastatin Calcium Generic | 116 | 284 | 29 | $1,269 |
Brand drugs: 3,234 claims; generic drugs: 3,165 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Stephanie Curry $38.36 ($38.36 in general payments such as food, travel and fees) from 1 company. The largest payer was Collegium Pharmaceutical, Inc. with $38.36.
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. COLL | 2 | $38.36 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.